88 related articles for article (PubMed ID: 9108468)
1. Mutations in the long control region of human papillomavirus DNA in oral cancer cells, and their functional consequences.
Chen Z; Storthz KA; Shillitoe EJ
Cancer Res; 1997 Apr; 57(8):1614-9. PubMed ID: 9108468
[TBL] [Abstract][Full Text] [Related]
2. [YY1 and its repressive effect on human papillomavirus 16 early promoter P97 existed widely among human epithelial cell lines].
Dong X; Liu H; Pfister H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Sep; 12(3):217-22. PubMed ID: 12526319
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activation of the human papillomavirus type 5 and 16 long control region in cells from cutaneous and mucosal origin.
Mistry N; Simonsson M; Evander M
Virol J; 2007 Mar; 4():27. PubMed ID: 17352804
[TBL] [Abstract][Full Text] [Related]
4. Effects of human papillomavirus type 18-specific antisense oligonucleotides on the transformed phenotype of human carcinoma cell lines.
Steele C; Cowsert LM; Shillitoe EJ
Cancer Res; 1993 May; 53(10 Suppl):2330-7. PubMed ID: 7683572
[TBL] [Abstract][Full Text] [Related]
5. HPV-2 isolates from patients with huge verrucae vulgaris possess stronger promoter activities.
Lei YJ; Wang C; Gao C; Jiang HY; Chen JM; Han J; Yuan YK; Dong XP
Intervirology; 2007; 50(5):353-60. PubMed ID: 17728546
[TBL] [Abstract][Full Text] [Related]
6. Identification and functional analysis of sequence rearrangements in the long control region of human papillomavirus type 16 Af-1 variants isolated from Ugandan penile carcinomas.
Tornesello ML; Buonaguro FM; Buonaguro L; Salatiello I; Beth-Giraldo E; Giraldo G
J Gen Virol; 2000 Dec; 81(Pt 12):2969-2982. PubMed ID: 11086128
[TBL] [Abstract][Full Text] [Related]
7. State of p53, Rb and DCC tumor suppressor genes in human oral cancer cell lines.
Kim MS; Li SL; Bertolami CN; Cherrick HM; Park NH
Anticancer Res; 1993; 13(5A):1405-13. PubMed ID: 8239512
[TBL] [Abstract][Full Text] [Related]
8. Lipofection-mediated immortalization of human prostatic epithelial cells of normal and malignant origin using human papillomavirus type 18 DNA.
Weijerman PC; König JJ; Wong ST; Niesters HG; Peehl DM
Cancer Res; 1994 Nov; 54(21):5579-83. PubMed ID: 7923200
[TBL] [Abstract][Full Text] [Related]
9. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
10. The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation.
Badal S; Badal V; Calleja-Macias IE; Kalantari M; Chuang LS; Li BF; Bernard HU
Virology; 2004 Jul; 324(2):483-92. PubMed ID: 15207633
[TBL] [Abstract][Full Text] [Related]
11. Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma.
Nemes JA; Deli L; Nemes Z; Márton IJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):344-52. PubMed ID: 16920543
[TBL] [Abstract][Full Text] [Related]
12. Different P105 promoter activities among natural variants of human papillomavirus type 18.
Sichero L; Franco EL; Villa LL
J Infect Dis; 2005 Mar; 191(5):739-42. PubMed ID: 15688288
[TBL] [Abstract][Full Text] [Related]
13. Activity of human papillomavirus type 16 P97 promoter in immortal and tumorigenic human oral keratinocytes.
Kook JK; Kim JH; Min BM
Int J Oncol; 1998 Oct; 13(4):765-71. PubMed ID: 9735407
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus: its identity and controversial role in oral oncogenesis, premalignant and malignant lesions (review).
Campisi G; Panzarella V; Giuliani M; Lajolo C; Di Fede O; Falaschini S; Di Liberto C; Scully C; Lo Muzio L
Int J Oncol; 2007 Apr; 30(4):813-23. PubMed ID: 17332919
[TBL] [Abstract][Full Text] [Related]
15. Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity.
Ha PK; Pai SI; Westra WH; Gillison ML; Tong BC; Sidransky D; Califano JA
Clin Cancer Res; 2002 May; 8(5):1203-9. PubMed ID: 12006539
[TBL] [Abstract][Full Text] [Related]
16. [No switch region is found in the regulatory sequence of HPV 16 for promoter P97].
Dong X; Liu H; Pfister H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Dec; 13(4):325-7. PubMed ID: 12759968
[TBL] [Abstract][Full Text] [Related]
17. [Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].
Velazquez Torres A; Gariglio Vidal P
Rev Invest Clin; 2002; 54(3):231-42. PubMed ID: 12183893
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997.
Miller CS; Johnstone BM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jun; 91(6):622-35. PubMed ID: 11402272
[TBL] [Abstract][Full Text] [Related]
19. Mutational analyses of differentiation-dependent human papillomavirus type 18 enhancer elements in epithelial raft cultures of neonatal foreskin keratinocytes.
Parker JN; Zhao W; Askins KJ; Broker TR; Chow LT
Cell Growth Differ; 1997 Jul; 8(7):751-62. PubMed ID: 9218869
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaction.
Harnish DG; Belland LM; Scheid EE; Rohan TE
Mol Cell Probes; 1999 Feb; 13(1):9-21. PubMed ID: 10024428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
